Blog
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Blog
Photo of Toni Choueiri from X
May 27, 2024, 04:18
Toni Choueiri: My Top* 10 pending LBAs
Toni Choueiri
shared a post on LinkedIn:
“Pending LBAs, my Top* 10.”
Source:
Toni Choueiri/LinkedIn
ASCO24
cancer
OncoDaily
Oncology
Toni Choueiri
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
Facebook
RSS Feed
Twitter
Linkedin
Youtube
Insight
Jul 4, 2024, 13:06
Affimed Reports First Quarter 2024 Updates
Blog
Jul 4, 2024, 13:06
Laura Bukavina: NTACT residual disease test presented by Phillip Abbosh
Blog
Jul 4, 2024, 12:54
Children's Cancer Institute will be sharing stories of families affected by sarcoma diagnosis
Blog
Jul 4, 2024, 12:53
Jill Squire: ‘Straight Outta Healthcare IT’ moved me beyond words
Insight
Jul 4, 2024, 12:47
Johanna Joyce: We explore the brain metastasis niche
Blog
Jul 4, 2024, 12:45
Isabel Mestres: Sometimes, common sense isn't as common as we think
Opinion
Jul 4, 2024, 12:43
Mohit Manrao: When it comes to the world of AI, optimism drives my perspective
Blog
Jul 4, 2024, 12:39
Pat Keel: I’m so honored to be recognized with such an outstanding group of finance leaders!
Societies
Jul 4, 2024, 12:36
SIOP Europe enthusiastic about collaborating on the EU Pharma and advancing efforts in childhood cancer
Blog
Jul 4, 2024, 12:28
Emir Sokolović: The largest study focusing on young women with breast cancer carrying germline BRCA PV
Blog
Jul 4, 2024, 12:20
Aman Chauhan: Rare and aggressive cancer requires funding to develop better treatments
Blog
Jul 4, 2024, 12:15
Angela Lamarca: We MUST validate innovate biomarkers in clinical trials